Literature DB >> 23536654

Lymphoid-tissue stromal cells coordinate innate defense to cytomegalovirus.

Shilpi Verma1, Qiao Wang, Grzegorz Chodaczek, Chris A Benedict.   

Abstract

During mouse cytomegalovirus (MCMV) infection, the first wave of type I interferon (IFN-I) production peaks at ≈ 8 h. This IFN-I emanates from splenic stromal cells located in the marginal zone (MZ) and requires B cells that express lymphotoxin. The amount of IFN-I produced at these initial times is at least equivalent in magnitude to that produced later by dendritic cells (≈ 36 to 48 h), but the relative roles of these two IFN-I sources in regulating MCMV defense remain unclear. Here we show that IFN-I produced by MZ stromal cells dramatically restricts the first measurable burst of viral production, which occurs at ≈ 32 h. This primary innate control by IFN-I is partially mediated through the activation of natural killer (NK) cells, which produce gamma interferon in an IFN-I-dependent fashion, and is independent of Ly49H. Strikingly, MCMV production in the spleens of immunocompetent mice never increases at times after 32 h. These results highlight the critical importance of lymphoid-tissue stromal cells in orchestrating the earliest phase of innate defense to MCMV infection, capping replication levels, and blocking spread until infection is ultimately controlled.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23536654      PMCID: PMC3648091          DOI: 10.1128/JVI.00113-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  64 in total

1.  Cutting edge: selective IL-18 requirements for induction of compartmental IFN-gamma responses during viral infection.

Authors:  G C Pien; A R Satoskar; K Takeda; S Akira; C A Biron
Journal:  J Immunol       Date:  2000-11-01       Impact factor: 5.422

Review 2.  Modulation of host innate and adaptive immune defenses by cytomegalovirus: timing is everything.

Authors:  A Loewendorf; C A Benedict
Journal:  J Intern Med       Date:  2010-05       Impact factor: 8.989

3.  Tissue-specific positive feedback requirements for production of type I interferon following virus infection.

Authors:  Arun Prakash; Eric Smith; Chien-Kuo Lee; David E Levy
Journal:  J Biol Chem       Date:  2005-03-14       Impact factor: 5.157

Review 4.  Insights into viral transmission at the uterine-placental interface.

Authors:  Lenore Pereira; Ekaterina Maidji; Susan McDonagh; Takako Tabata
Journal:  Trends Microbiol       Date:  2005-04       Impact factor: 17.079

Review 5.  The PYHIN protein family as mediators of host defenses.

Authors:  Stefan A Schattgen; Katherine A Fitzgerald
Journal:  Immunol Rev       Date:  2011-09       Impact factor: 12.988

6.  Cloning and mutagenesis of a herpesvirus genome as an infectious bacterial artificial chromosome.

Authors:  M Messerle; I Crnkovic; W Hammerschmidt; H Ziegler; U H Koszinowski
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

7.  Interferon-alpha/beta inhibition of interleukin 12 and interferon-gamma production in vitro and endogenously during viral infection.

Authors:  L P Cousens; J S Orange; H C Su; C A Biron
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

8.  DAI/ZBP1/DLM-1 complexes with RIP3 to mediate virus-induced programmed necrosis that is targeted by murine cytomegalovirus vIRA.

Authors:  Jason W Upton; William J Kaiser; Edward S Mocarski
Journal:  Cell Host Microbe       Date:  2012-03-15       Impact factor: 21.023

9.  Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection.

Authors:  Khuong B Nguyen; Thais P Salazar-Mather; Marc Y Dalod; Jeffrey B Van Deusen; Xiao-qing Wei; Foo Y Liew; Michael A Caligiuri; Joan E Durbin; Christine A Biron
Journal:  J Immunol       Date:  2002-10-15       Impact factor: 5.422

10.  Lymphotoxin-mediated crosstalk between B cells and splenic stroma promotes the initial type I interferon response to cytomegalovirus.

Authors:  Kirsten Schneider; Andrea Loewendorf; Carl De Trez; James Fulton; Antje Rhode; Heather Shumway; Sukwon Ha; Ginelle Patterson; Klaus Pfeffer; Sergei A Nedospasov; Carl F Ware; Chris A Benedict
Journal:  Cell Host Microbe       Date:  2008-02-14       Impact factor: 21.023

View more
  16 in total

1.  Distinct requirements for activation of NKT and NK cells during viral infection.

Authors:  Aaron J Tyznik; Shilpi Verma; Qiao Wang; Mitchell Kronenberg; Chris A Benedict
Journal:  J Immunol       Date:  2014-03-14       Impact factor: 5.422

2.  Chronic alcohol consumption exacerbates murine cytomegalovirus infection via impairing nonspecific and specific NK activation in mice.

Authors:  Alex Little; Yuanfei Li; Faya Zhang; Hui Zhang
Journal:  FASEB Bioadv       Date:  2018-09-14

3.  Cytomegalovirus-Specific CD4 T Cells Are Cytolytic and Mediate Vaccine Protection.

Authors:  Shilpi Verma; Daniela Weiskopf; Ankan Gupta; Bryan McDonald; Bjoern Peters; Alessandro Sette; Chris A Benedict
Journal:  J Virol       Date:  2015-10-21       Impact factor: 5.103

4.  cGAS-STING Signaling Regulates Initial Innate Control of Cytomegalovirus Infection.

Authors:  Chan-Wang J Lio; Bryan McDonald; Mariko Takahashi; Rekha Dhanwani; Nikita Sharma; Jenny Huang; Elise Pham; Chris A Benedict; Sonia Sharma
Journal:  J Virol       Date:  2016-08-12       Impact factor: 5.103

5.  Cardif (MAVS) Regulates the Maturation of NK Cells.

Authors:  LaTeira D Haynes; Shilpi Verma; Bryan McDonald; Runpei Wu; Robert Tacke; Heba N Nowyhed; Jennifer Ekstein; Ariana Feuvrier; Chris A Benedict; Catherine C Hedrick
Journal:  J Immunol       Date:  2015-07-31       Impact factor: 5.422

Review 6.  Cytomegalovirus: Shape-Shifting the Immune System.

Authors:  Gaëlle Picarda; Chris A Benedict
Journal:  J Immunol       Date:  2018-06-15       Impact factor: 5.422

7.  Inhibition of the TRAIL death receptor by CMV reveals its importance in NK cell-mediated antiviral defense.

Authors:  Shilpi Verma; Andrea Loewendorf; Qiao Wang; Bryan McDonald; Alec Redwood; Chris A Benedict
Journal:  PLoS Pathog       Date:  2014-08-14       Impact factor: 6.823

8.  Lymphotoxin-LIGHT pathway regulates the interferon signature in rheumatoid arthritis.

Authors:  Jadwiga Bienkowska; Norm Allaire; Alice Thai; Jaya Goyal; Tatiana Plavina; Ajay Nirula; Megan Weaver; Charlotte Newman; Michelle Petri; Evan Beckman; Jeffrey L Browning
Journal:  PLoS One       Date:  2014-11-18       Impact factor: 3.240

9.  Neutrophils recruited by IL-22 in peripheral tissues function as TRAIL-dependent antiviral effectors against MCMV.

Authors:  Maria A Stacey; Morgan Marsden; Tu Anh Pham N; Simon Clare; Garry Dolton; Gabrielle Stack; Emma Jones; Paul Klenerman; Awen M Gallimore; Philip R Taylor; Robert J Snelgrove; Trevor D Lawley; Gordon Dougan; Chris A Benedict; Simon A Jones; Gavin W G Wilkinson; Ian R Humphreys
Journal:  Cell Host Microbe       Date:  2014-04-09       Impact factor: 21.023

10.  Reversible silencing of cytomegalovirus genomes by type I interferon governs virus latency.

Authors:  Franziska Dağ; Lars Dölken; Julia Holzki; Anja Drabig; Adrien Weingärtner; Johannes Schwerk; Stefan Lienenklaus; Ianina Conte; Robert Geffers; Colin Davenport; Ulfert Rand; Mario Köster; Siegfried Weiß; Barbara Adler; Dagmar Wirth; Martin Messerle; Hansjörg Hauser; Luka Cičin-Šain
Journal:  PLoS Pathog       Date:  2014-02-20       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.